bf/NASDAQ:INM_icon.png

NASDAQ:INM

InMed Pharmaceuticals Inc.

  • Stock

USD

Last Close

1.71

06/11 22:18

Market Cap

2.35M

Beta: 1.06

Volume Today

42.41K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
asset turnover
0.09
-
0.29
244.12%
0.68
133.54%
cash conversion cycle
915.29
-
166.20
81.84%
80.85
51.35%
cash per share
2.40
-
0.57
76.08%
47.57
8,178.76%
116.59
145.10%
66.35
43.10%
27.94
57.88%
27.57
1.35%
11.09
59.76%
21.81
96.60%
0.87
96.02%
company equity multiplier
1.05
-
1.60
52.50%
1.05
34.59%
1.03
1.13%
1.09
4.95%
1.34
23.79%
1.33
1.35%
1.41
6.23%
1.17
17.16%
1.28
10.06%
days of inventory outstanding
1.67K
-
215.91
87.04%
64.94
69.92%
days of payables outstanding
779.67
-
72.69
90.68%
days of sales outstanding
29.49
-
22.98
22.07%
15.91
30.77%
dividend yield
ebit per revenue
-12.57
-
-1.98K
15,627.26%
-0.98
99.95%
ebt per ebit
1.00
-
1.00
0.10%
1.00
0.01%
0.99
1.05%
0.97
1.51%
0.99
1.88%
1.03
3.55%
1.36
32.07%
0.00
99.93%
0.97
99,742.33%
effective tax rate
-0.00
-
-0.00
97.44%
-0.00
451.92%
0.02
14,550.75%
0.03
24.79%
-0.00
108.26%
-0.04
1,546.97%
-0.26
631.96%
-0.00
99.36%
0.00
156.08%
enterprise value multiple
-2.86
-
-3.40
18.86%
-7.31
115.00%
-13.90
90.14%
-4.64
66.61%
-4.47
3.70%
-1.46
67.41%
-0.09
93.72%
0.81
983.44%
0.54
33.43%
fixed asset turnover
1.20
-
5.72
374.49%
6.48
13.28%
free cash flow per share
-28.86
-
-5.30
81.62%
-22.00
314.77%
-20.82
5.35%
-32.38
55.53%
-34.45
6.38%
-36.43
5.76%
-27.86
23.54%
-3.04
89.07%
-0.00
99.97%
gross profit margin
0.50
-
0.34
32.00%
0.14
59.91%
interest coverage
-979.95
-
-38.34K
3,812.55%
-6.95K
81.88%
-97.47
98.60%
-469.59
-
-27.54
94.14%
-142.53
417.63%
inventory turnover
0.22
-
1.69
671.38%
5.62
232.46%
long term debt to capitalization
0.04
-
0.03
41.08%
0.04
64.43%
0.00
96.79%
0.07
4,854.77%
net income per ebt
1
-
1
0%
1
0%
1
0%
0.97
2.60%
1.00
2.89%
1.04
3.31%
1.26
21.56%
1.00
20.41%
1.00
0.26%
net profit margin
-21.49
-
-1.92
91.06%
-0.95
50.75%
operating cash flow per share
-28.77
-
-5.29
81.61%
-21.82
312.31%
-20.57
5.69%
-32.25
56.75%
-34.25
6.19%
-36.42
6.36%
-27.79
23.71%
-2.98
89.28%
-0.00
99.97%
operating cycle
1.69K
-
238.89
85.91%
80.85
66.16%
operating profit margin
-12.57
-
-1.98K
15,627.26%
-0.98
99.95%
payables turnover
0.47
-
5.02
972.61%
pretax profit margin
-17.07
-
-1.92
88.76%
-0.95
50.62%
price fair value
7.68
-
7.97
3.70%
4.86
39.04%
5.24
7.91%
4.14
21.06%
7.85
89.80%
2.90
63.11%
0.73
74.94%
0.19
74.17%
0.21
11.08%
receivables turnover
12.38
-
15.88
28.32%
22.94
44.45%
return on assets
-2.58
-
-1.51
41.57%
-0.54
64.46%
-0.30
43.42%
-0.65
114.88%
-1.16
77.78%
-1.08
6.89%
-1.83
69.50%
-0.56
69.22%
-0.65
15.02%
return on capital employed
-2.71
-
-2.42
10.81%
-0.56
76.76%
-0.32
43.47%
-0.75
135.07%
-1.50
101.04%
-1.31
12.57%
-1.45
10.30%
-675.43
46,593.42%
-0.80
99.88%
return on equity
-2.71
-
-2.42
10.90%
-0.56
76.75%
-0.31
44.06%
-0.71
125.51%
-1.56
120.08%
-1.43
8.14%
-2.58
80.06%
-0.66
74.50%
-0.83
26.59%
total debt to capitalization
0.05
-
0.04
34.22%
0.08
127.90%
0.03
60.97%
0.07
108.59%

All numbers in USD (except ratios and percentages)